Literature DB >> 1271407

Cellular pharmocodynamics of several anthrocycline antibiotics.

N R Bachur, M Steele, W D Meriwether, R C Hildebrand.   

Abstract

Alterations in the C-9 side chain of the anthracycline antibiotics, adriamycin and daunorubicin, have a profound effect on antibiotic uptake and accumulation by cultured L1210 cells. The degree of inhibition of DNA and RNA biosynthesis in the L1210 cells is directly related to the cellular uptake and accumulation of the drug analogues. Polar drug metabolites, daunorubicinol and adriamycinol, retain inhibitory activity against nucleic acid metabolism but have a decreased membrane binding and permeability. Cellular uptake and accumulation of the C-9 analogues are inversely related to drug polarity. We propose that the polarity of the anthracycline analogues contributes heavily to the differences in therapeutic index and in vivo activity through fundamental effects on membrane permeability, metabolism, and macromolecular binding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1271407     DOI: 10.1021/jm00227a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

1.  Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo.

Authors:  B Sundman-Engberg; U Tidefelt; J Liliemark; C Paul
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.

Authors:  M J Kuffel; J M Reid; M M Ames
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.

Authors:  A Zenebergh; R Baurain; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Fluorinated anthracyclines: synthesis and biological activity.

Authors:  K C Tonkin; R T Brownlee; F Zunino; D R Phillips
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

5.  Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.

Authors:  C Paul; C Peterson; G Gahrton; D Lockner
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 6.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

7.  Comparative metabolism and elimination of adriamycin and 4'-epiadriamycin in the rat.

Authors:  T W Sweatman; M Israel
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.

Authors:  D L de Valeriola; D D Ross; A Forrest; D P Cuddy; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin.

Authors:  A Geier; R Beery; M Haimsohn; R Hemi; Z Malik; A Karasik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

10.  Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells.

Authors:  M W DeGregorio; G M Lui; B A Macher; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.